Reginald Williams II, an Avalere Health Director, discusses his organization’s analysis of how the oncology landscape may be the next topic of scrutiny for the Centers for Medicare & Medicaid Services. Four topics may be ripe for national coverage decisions: lung and prostate cancer screenings, localized prostate cancer treatments, therapies to manage non-small-cell lung cancer, and pharmacogenomic testing for breast and colon cancers.

Hear Williams’ discussion with OT Contributing Writer and “Practice Matters” blogger, Lola Butcher.